$PTPI Cashflow Statement | Understand Stock

$PTPI

$0.01 +$0.00 (20.0%) Close

$PTPI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Less loss from discontinued operations
Net income (loss) from continuing operations
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization
Intangible asset impairment
Bad debt expense (recoveries)
Inventory and sample inventory reserve
Amortization of deferred financing costs and debt discount
Lease expense
API asset impairment
Amortization of right of use asset
Change in fair value of warrant liability
Loss on issuance of Series A Preferred Stock
Noncash Warrant expense
Gain on settlement with Vivus
Non-employee stock-based compensation
Change in fair value of derivative liability
Deferred revenue
Warrant issuance costs
Gain from assignment of subsidiaries and Vivus settlement
Employee stock-based compensation
Stock issued for services
Deferred Income Tax Expense (Benefit)
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Deposits
Prepaid inventory
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Deferred revenue
Other current liabilities
Other long-term liabilities
Net cash used in operating activities - continuing operations
Net cash (used in) provided by operating activities - discontinued operations
Net cash used in operating activities

Cash flows from investing activities:
Acquisition of fixed assets
Net cash used in investing activities
Net cash used in investing activities - discontinued operations
Cash flows from financing activities:
Payment of equity issuance costs
Payment of promissory note
Payment of senior debt
Payment of portion of senior debt end of term fee
Proceeds from Issuance of Common Stock
Proceeds from exercise of warrants
Proceeds from Private Placement, net of transaction costs
Proceeds from common stock and prefunded warrants, net
Redemption of Series A Preferred Stock
Net cash provided by (used in) financing activities - continuing operations
Net cash used in financing activities - discontinued operations
Net cash provided by (used in) financing activities

Net (decrease) increase in cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Net increase (decrease) in cash
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Less: cash and cash equivalents attributable to discontinued operations
Cash and cash equivalents, end of year - continuing operations
Cash paid for interest during the period
Noncash items:
Noncash decrease in accrued expenses related to Vivus settlement
Noncash decrease in accrued inventory purchases related to Vivus Settlement
Noncash increase in promissory note related to Vivus settlement
Noncash increase in inventory due to API reclass
Noncash decrease in API purchase commitment
Noncash decrease in other current assets: API purchase commitment
Noncash issuance of common stock to non-employee
Noncash initial fair value of warrant liability pursuant to private placement
Noncash initial fair value of derivative liability pursuant to private placement
Noncash redemption of Series A Preferred Stock
Accrued Series A Preferred Stock payments payable
Accretion of Series A Preferred Stock to redemption value
Accrual of Series A Preferred Stock dividends
Reclass of warrant liability upon warrant modification
Non-cash warrant issuance costs
Cashless exercise of Series B warrants
Deemed dividend on warrants
Series A Preferred warrants
Series A Warrants

Comments